Latest News on Pfizer Inc. (PFE) Stock

  • NMC Health plc -- Moody's assigns first-time Ba1 ratings to NMC Health; outlook stable [April 22 2018 01:08 PM]
  • Moody's Investors Service, ("Moody's") has assigned a Ba1 corporate family rating (CFR) and Ba1-PD probability of default rating to NMC Health plc (NMC), the largest healthcare provider in the ... Read more about this Pfizer Inc. (PFE) news
  • Better Buy: Gilead Sciences, Inc. (GILD) vs. Pfizer (PFE) [April 22 2018 04:18 AM]
  • Which stock wins in a match-up between these huge drugmakers? Read more about this Pfizer Inc. (PFE) news


  • Analysts’ Ratings for Sarepta Therapeutics and Peers in April [April 20 2018 02:59 PM]
  • How Is Sarepta Therapeutics Positioned in 2018? Sarepta Therapeutics (SRPT) is a commercial stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics, gene therapy, and other genetic approaches for treating rare neuromuscular diseases. Of the 19 analysts covering Sarepta Therapeutics in April 2018, six analysts gave the stock a “strong buy” ... Read more about this Pfizer Inc. (PFE) news


  • P&G's vitamin boost could signal more to come [April 20 2018 07:23 AM]
  • LONDON/CHICAGO (Reuters) - Procter & Gamble's $4.2 billion deal for Merck's vitamin and supplements business demonstrates that major consumer companies remain hungry for health-related products. The fragmented nature of the sector and its appeal to younger consumers makes further M&A activity a likely prospect even after a spate of recent acquisitions. The U.S.-based maker of Tide detergent and ... Read more about this Pfizer Inc. (PFE) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center